Medical Researches
Possibly Effective
Based on 10 Researches
Nutritious formula aids diarrhea controlGastrointestinal tolerance and plasma status of carotenoids, EPA and DHA with a fiber-enriched tube feed in hospitalized patients initiated on tube nutrition: Randomized controlled trial.
Docosahexaenoic acid's unclear impact
We conducted a study to investigate the effects of a tube feeding formula enriched with dietary fiber, fish oil, and carotenoids on gastrointestinal tolerance, particularly focusing on diarrhea. Our research involved a multi-center, randomized, double-blind trial, where we compared this nutrient-rich formula to a standard isocaloric formula in 51 hospitalized patients requiring tube nutrition.
Over the course of the trial, we recorded the incidence of diarrhea and constipation based on stool frequency and consistency. Our findings suggested that patients receiving the enriched formula experienced fewer incidents of diarrhea than those on the standard formula. Additionally, after seven days, we noted significant improvements in plasma levels of essential nutrients like EPA, DHA, and carotenoids.
Overall, our study indicates that incorporating docosahexaenoic acid (DHA) along with dietary fiber and carotenoids in tube feeding could enhance gastrointestinal tolerance. This means that not only may it help reduce diarrhea among hospitalized patients, but it also potentially improves their nutritional status during a critical period of recovery.
Read More
DHA reduces diarrhea risk in infantsInfants fed formula with added long chain polyunsaturated fatty acids have reduced incidence of respiratory illnesses and diarrhea during the first year of life.
Study shows dietary intervention impact
We explored the effects of adding docosahexaenoic acid (DHA) to infant formula to find out if it influences the incidence of diarrhea among other illnesses. In a large, multicenter study, a total of 325 healthy infants participated, with 233 receiving formula enriched with DHA and arachidonic acid (ARA), while 92 were given standard formula without these supplements.
Throughout the year, pediatricians observed and documented the health of these infants, especially focusing on respiratory illnesses and instances of diarrhea. Our findings revealed that infants who consumed the DHA/ARA enhanced formula had a significantly lower rate of diarrhea that required medical attention compared to those who did not receive these fatty acids.
This research suggests that incorporating DHA into infant nutrition could potentially lead to fewer cases of diarrhea during the critical first year of life, among other health benefits. Overall, this highlights the importance of considering nutritional components in infant formulas to support better health outcomes.
Read More
We conducted a multicenter study to examine the impact of fish oil supplementation, rich in docosahexaenoic acid (DHA), on patients suffering from active ulcerative colitis and the associated symptom of diarrhea. The study included 24 patients who were randomly assigned to receive either fish oil or a placebo over four months, with treatment periods separated by a one-month washout.
Throughout the study, participants continued their regular medications, which included prednisone and sulfasalazine. The results were promising; we observed noticeable improvements in the patients' histology, reduced levels of leukotriene B4—which is linked to inflammation—and even some weight gain. However, while there were benefits related to inflammation markers and histologic findings, we cannot exclusively credit DHA for improvements in diarrhea, as other treatments were also in play.
Ultimately, the findings indicated that fish oil, with its DHA component, may contribute positively to managing ulcerative colitis, but further investigation is needed to clarify its specific effects on diarrhea alone. Thus, while there is potential, we should approach the results with some caution regarding the direct link to diarrhea relief.
Read More
Our exploration into the impact of fatty acids, specifically eicosapentaenoic acid (EPA) and docosahexaenoic acid (DHA), on porcine coronaviruses revealed noteworthy findings. We found that these acids significantly reduce the viral load of several dangerous porcine viruses, including the ones responsible for diarrhea in pigs, like porcine epidemic diarrhea virus (PEDV). This reduction occurs during viral replication, rather than hindering the virus's ability to enter the cells, indicating a specific action against the viral lifecycle.
We confirmed that both DHA and EPA help in reducing inflammation and lowering reactive oxygen species (ROS) levels within cells infected by these viruses. By doing so, they also enhance the overall antioxidant capacity of the cells, providing a protective effect against the stress caused by the viruses. Overall, our findings suggest that EPA, along with DHA, could play a critical role in developing new approaches to managing infection and, consequently, controlling outbreaks of diarrhea-causing viruses in the swine industry.
These findings are particularly relevant as we look for effective treatments to combat the viral threats facing livestock and, by extension, the agricultural economy. Thus, the antiviral properties of these fatty acids provide a promising avenue for future research and therapeutic development.
Read More
Nutritional management in SAH patientsEarly Enteral Nutrition with High-Protein Whey Peptide Digestive Nutrients May Improve Prognosis in Subarachnoid Hemorrhage Patients.
Diarrhea findings inconclusive with EPA
We explored the effect of early enteral nutrition on patients who suffered a subarachnoid hemorrhage (SAH). In a retrospective study involving 245 patients, we compared two different liquid diets: one rich in high-protein whey peptide and the other containing eicosapentaenoic acid (EPA).
Our focus was on understanding how these diets impacted patients' health outcomes, especially regarding diarrhea. While we noticed that the high-protein whey peptide group had a lower rate of diarrhea (about 15.8%) compared to the EPA group (34.3%), we couldn’t isolate the effects of EPA specifically on gastrointestinal issues.
Overall, the study indicated that the choice of nutrients in enteral feeding could influence recovery and comfort for SAH patients. However, it’s important to note that the findings on eicosapentaenoic acid alone did not demonstrate any significant benefit regarding diarrhea in this context.
Read More
User Reviews
Moderately Good
Based on 2 Reviews
Initial diarrhoea experience
If you're seeking high-quality omega 3s, this option is good. Each capsule contains 750mg of omega 3 (500 DHA + 250 EPA), so I take at least 2 capsules daily, as the minimum recommended dose is 1200mg/day for benefits. Initially, I experienced diarrhoea, but I've adjusted now. I advise consulting a doctor regarding blood thinners and stopping omega 3 at least 2 weeks before any surgery. The product is distilled and comes well packaged, although it has less taste and smell.
Read More
Severe reactions reported
After taking DHA-500, I had several severe allergic reactions, becoming violently ill with diarrhoea all day, which led to dehydration and a hospital visit. I am sure some people might not have this problem, but it affected me severely.